Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 83/100

Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 12:00PM GMT
Release Date Price: $60.81 (-0.02%)
Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst

Well, thanks. Good morning, everybody. Thanks for joining us. I'm Terence Flynn, the U.S. biopharma analyst at Morgan Stanley. Very pleased to kick off the conference this morning with Bristol-Myers.

Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, reach out to your Morgan Stanley sales rep.

Joining us today from the company, we have Giovanni Caforio, Chairman and CEO; and Chris Boerner, who is Chief Operating Officer and CEO-Elect, will take over in November. But thank you very much, both, for being here. And congrats, both, on next steps.

Giovanni Caforio
Bristol-Myers Squibb Company - Chairman of the Board & CEO

Thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot